astarior 10 mg / 5 mg kapseli, kova
les laboratoires servier - atorvastatinum calcicum trihydricum,perindoprilum argininum - kapseli, kova - 10 mg / 5 mg - atorvastatiini ja perindopriili
astarior 20 mg / 5 mg kapseli, kova
les laboratoires servier - atorvastatinum calcicum trihydricum,perindoprilum argininum - kapseli, kova - 20 mg / 5 mg - atorvastatiini ja perindopriili
astarior 40 mg / 5 mg kapseli, kova
les laboratoires servier - atorvastatinum calcicum trihydricum,perindoprilum argininum - kapseli, kova - 40 mg / 5 mg - atorvastatiini ja perindopriili
astarior 10 mg / 10 mg kapseli, kova
les laboratoires servier - perindoprilum argininum,atorvastatinum calcicum trihydricum - kapseli, kova - 10 mg / 10 mg - atorvastatiini ja perindopriili
astarior 20 mg / 10 mg kapseli, kova
les laboratoires servier - perindoprilum argininum,atorvastatinum calcicum trihydricum - kapseli, kova - 20 mg / 10 mg - atorvastatiini ja perindopriili
astarior 40 mg / 10 mg kapseli, kova
les laboratoires servier - perindoprilum argininum,atorvastatinum calcicum trihydricum - kapseli, kova - 40 mg / 10 mg - atorvastatiini ja perindopriili
viant infuusiokuiva-aine, liuosta varten
b. braun melsungen ag - ascorbic acid, biotin, colecalciferol, cyanocobalamin, riboflavin sodium fosfate, nicotinamide, pyridoxine hydrochloride, retinol palmitate, thiamine hydrochloride, all-rac-alfa-tocopherol, pantothenic acid, all-rac-phytomenadione, folic acid hydrate - infuusiokuiva-aine, liuosta varten - 932 mg - vitamiinit
trodelvy
gilead sciences ireland uc - sacituzumab govitecan - breast neoplasms; triple negative breast neoplasms - antineoplastiset aineet - trodelvy as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (mtnbc) who have received two or more prior systemic therapies, including at least one of them for advanced disease.